Masimo logo

Masimo

Stock
Stock
Ticker: MASI
MASI

Price

Price

CHART BY

Historical dividends and forecast

 

0.221

CHART BY

Frequently asked questions

The market capitalization of Masimo is $8.53B. Market capitalization is a measure of the total market value of a publicly traded company. It is calculated by multiplying the current stock price by the total number of outstanding shares.
The Price-to-Earnings (P/E) ratio (TTM) for Masimo is 2,105.34. This ratio helps investors assess whether a stock is overvalued or undervalued compared to its earnings.
Masimo's Earnings Per Share (EPS) over the trailing twelve months (TTM) is $1.458. EPS indicates the company's profitability on a per-share basis.
Currently, 1 analysts cover Masimo's stock, with a consensus target price of $180.00. Analyst ratings provide insights into the stock's expected performance.
Over the trailing twelve months, Masimo reported a revenue of $1.56B.
Masimo's Earnings before interest, taxes, depreciation, and amortization (EBITDA) over the trailing twelve months is $347.70M. EBITDA measures the company's overall financial performance.
Masimo has a free cash flow of $210.90M. Free cash flow indicates the cash generated after accounting for cash outflows to support operations and capital assets.
Masimo employs approximately 7,500 people. It operates in the Health Care sector, specifically within the Medical Specialties industry.
The free float of Masimo is 50.83M. Free float refers to the number of shares available for public trading, excluding restricted shares.

Financials

Market Cap 
$8.53B
EPS (TTM) 
$1.458
Free Float 
50.83M
P/E ratio (TTM) 
2,105.34
Revenue (TTM) 
$1.56B
EBITDA (TTM) 
$347.70M
Free Cashflow (TTM) 
$210.90M

Analyst Ratings

The price target is $180.00 and the stock is covered by 1 analysts.

Buy

0

Hold

1

Sell

0

Information

Masimo Corp. is a global technology company, which engages in the development, manufacture, and marketing of patient monitoring technologies, and automation and connectivity solutions. Its products include remote patient monitoring, connectivity, and hospital automation solutions, including Masimo Patient SafetyNet, Masimo Patient SafetyNet Surveillance, Masimo SafetyNet, Masimo SafetyNet-Open, Replica, Iris, MyView, UniView, Uniview: 60, Trace, Masimo Sleep, Centroid, and Bridge. It operates through the following segments: Healthcare and Non-Healthcare. The Healthcare segment develops, manufactures, and markets a variety of noninvasive monitoring technologies and hospital automation solutions and therapeutics. The Non-Healthcare segment designs, develops, manufactures, markets and sells a broad portfolio of premium, high-performance audio products and services. The company was founded by Joe E. Kiani in May 1989 and is headquartered in Irvine, CA.

Employees
7,500
Industries
Medical Specialties
Sector
Health Care

Identifier

Primary Ticker
MASI

Knockouts

Real-time data from LSX · Fundamentals & EOD data from FactSet
Join the conversation
Sign upLogin